Skip to content
Cultural Foundation
Author:
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy
June 17, 2026